J Korean Ophthalmol Soc.  2000 Sep;41(9):1815-1823.

Immunohistochemical Findings in the Early Ischemic Retina of Gerbil Model

Affiliations
  • 1Department of Ophthalmology, Chun-Cheon Sacred Heart Hospital, The Hallym University, Medical College, #153 Kyo-dong, Chun-cheon City, Kang-won Do, 200-704, Korea.

Abstract

Gerbil has no Willis circle so we can make the model of cerebral ischemia simply by occluding the common carotid artery. In this study, we occluded the common carotid arteries of the gerbil for 5 minutes, and at the designated reperfusion time (0.5, 3, 6, 12 and 24 hrs), the experimental animals were killed for histopathological and neurofilament 68 kDa immunohistochemical study. At 12 hrs after ischemia the neuronal cell change occurred in inner nuclear layer (INL)and ganglion cell layer (GCL). At 24 hrs after ischemia the disappearance of neurons were observed in GCL and severe edema, pyknotic degeneration were observed in INL and outer nuclear layer (ONL ). On immunohistochemical study, the NF 68 kDa antibody labelled the cell bodies in the GCL and some nerve fibers in nerve fiber layer (NFL). In addition, the processes of horizontal cells also showed the slight NF 68 kDa immunoreactivity. After ischemic insult, the intensity of NF 68 kDa immunoreactivity in GCL and NFL was slightly decreased. But, its intensity in the process of horizontal cells was increased. And the NF 68 kDa immunoreacticity was detected in some neurons of INL and ONL. This represents the neurofilament protein has the important role in the cell death at the ischemic retina as well as at the ischemic brain.

Keyword

Gerbil; Ischemia; NF 68 kDa; Retina

MeSH Terms

Animals
Brain
Brain Ischemia
Carotid Artery, Common
Cell Death
Circle of Willis
Edema
Ganglion Cysts
Gerbillinae*
Ischemia
Nerve Fibers
Neurons
Reperfusion
Retina*
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr